results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation. 2014;129(25):2638-2644.

A velocity of < 0.4 m/s indicates a higher risk, in general, of thromboembolism. Cardiac CT can be used, as well. During atrial fibrillation and atrial flutter, the left atrial appendage loses ...

This leads to stagnant blood in the appendage, which causes clot formation ( thrombosis). Risk factors for atrial fibrillation include: The heart's main pumping chambers, the ventricles ...

Two studies led by researchers at the Broad Institute of MIT and Harvard and Mass General Brigham have greatly expanded the ...

Atrial flutter is similar to atrial fibrillation (AF) in regard to symptoms and thromboembolic risk, including stroke. However, the pathophysiology and management differ. Symptoms of AF reflect ...

In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...

subclinical atrial fibrillation, venous thromboembolism, or stroke. The risk for major bleeding and intracranial hemorrhage did not differ between apixaban and aspirin (absolute risk difference ...

Discover how botanical and nutrient therapies provided adjunctive support for a 76-year-old patient with treatment-resistant ...

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...

Medscape Medical News, November 15, 2022 AHA 2022 First-Line AF Ablation Cuts Risk of Progression vs Drug Therapy Atrial fibrillation ... AHA 2022 EHR-based Thromboembolism Risk Tools Boosts ...

Background A 60-year-old male with obesity (body-mass index 43 kg/m 2) presented with recurrent symptomatic atrial fibrillation (AF), which he had had since age 41 years. The AF was refractory to ...